文献速递神经肿瘤神经重症

乌干达中枢神经系统肿瘤:手术治疗结局与电话调查评估的并发症

Central Nervous System Tumors in Uganda: Outcomes of Surgical Treatment and Complications Assessed Through Telephone Survey.
PubMed 文献 · World Neurosurg · 2019-06-15

本研究基于2014–2015年Mulago国家转诊医院神经外科病房的前瞻性数据库,对112例中枢神经系统肿瘤患者进行电话随访,评估手术结局与并发症。结果显示住院死亡率18%、30天死亡率22%、1年死亡率35%;30%患者接受肿瘤切除,其中位总生存期66.5个月优于非手术患者的5.1个月(P=0.025)。胶质母细胞瘤患者中位总生存期0.83个月,低于脑膜瘤的59个月(P=0.02)。

要点

  • 手术切除与更长的中位总生存期相关(66.5个月 vs 5.1个月,P=0.025)
  • 胶质母细胞瘤预后差,中位总生存期0.83个月
  • 电话调查应答率85%,多数幸存者获得随访照护

核心结论

  • 在Mulago国家转诊医院接受手术治疗与改善的总生存期相关。
  • 电话访谈是有效的健康结局随访方法,多数患者确实寻求随访照护。

研究设计与样本

  • 基于2014–2015年Mulago国家转诊医院神经外科病房的前瞻性数据库收集住院患者数据。
  • 使用电话调查以患者语言评估随访健康状况,并分析影响患者结局的因素。

主要发现

  • 共纳入112例中枢神经系统肿瘤患者(成人87例,女性70%,中位年龄37岁)。
  • 脑膜瘤(21%)是最常见的肿瘤诊断。
  • 住院死亡率18%,30天死亡率22%,1年死亡率35%。
  • 30%患者接受住院肿瘤切除,其中位总生存期66.5个月,非手术患者为5.1个月(P=0.025)。
  • 有病理诊断者中,胶质母细胞瘤中位总生存期0.83个月,脑膜瘤为59个月(P=0.02)。

临床怎么用

  • 在资源有限地区,手术治疗可能与中枢神经系统肿瘤患者更长的总生存期相关。
  • 电话调查可作为有效的随访方式,用于评估术后结局与并发症。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

BACKGROUND: Uganda has one of the largest unmet neurosurgical needs in the world, but has seen major improvements in neurosurgery-largely centered at Mulago National Referral Hospital (MNRH). This study implements the first long-term follow-up and outcomes analysis of central nervous system tumor patients in Uganda. METHODS: Inpatient data were collected using a prospective database of patients presenting to the MNRH neurosurgical ward between 2014 and 2015. Follow-up health care status was assessed in the patient's language using phone surveys. Analysis was performed to identify which factors were associated with patient outcomes. RESULTS: The MNRH neurosurgical ward saw 112 patients with central nervous system tumors (adult N = 87, female: 70%, median age: 37 years). Meningiomas (21%) comprised the most common tumor diagnosis. In-hospital mortality (18%), 30-day mortality (22%), and 1-year mortality (35%) were high. Thirty percent of patients underwent tumor resection in-patient and had greater median overall survival (66.5 months vs. 5.1 months for nonsurgical patients, P = 0.025). For those with known pathologic diagnoses, patients with glioblastomas had decreased median overall survival (0.83 months vs. 59 months for meningiomas, P = 0.02). Phone interviews yielded an 85% response rate. Of the survivors at the time of follow-up, 55% reported a subjective return to normalcy, and 75% received follow-up care for their tumor with most returning to MNRH. CONCLUSIONS: We show evidence for improved overall survival with surgical care at MNRH. In addition, phone interviews as a method of measuring health outcomes provided an effective means of follow-up, showing that most patients do seek follow-up care.

来源:World Neurosurg,查看原文。版权归原作者所有。

引用

  1. Kakusa BW, Xu LW, Vaca SD, et al. Central Nervous System Tumors in Uganda: Outcomes of Surgical Treatment and Complications Assessed Through Telephone Survey. World Neurosurg. 2019. PMID: 31303566. doi:10.1016/j.wneu.2019.06.060

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。